Belgium
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.41 B
|
Dec. 31, 2023 | USD 194.45 | 1.55% |
|
Belgium |
|
2 |
USD 148.04 M
|
Dec. 31, 2023 | USD 19.73 | 0.25% |
|
Belgium |
|
3 |
USD 48.82 M
|
Dec. 31, 2023 | USD 22.74 | -0.48% |
|
Belgium |
|
4 |
USD -30.47 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
5 |
USD -32.16 M
|
Dec. 31, 2023 | USD 2.24 | -2.03% |
|
Belgium |
|
6 |
USD -46.45 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
The Healthcare company in Belgium with the highest EBITDA is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 1.41 B.
The Healthcare company in Belgium with the lowest EBITDA is Nyxoah S.A. (NasdaqGM: NYXH) at USD -46.45 M.
The top 10 Healthcare companies in Belgium by EBITDA are UCB SA, Fagron NV, Galapagos NV, MDxHealth SA, Sequana Medical NV and Nyxoah S.A..
The bottom 10 Healthcare companies in Belgium by EBITDA are Nyxoah S.A., Sequana Medical NV, MDxHealth SA, Galapagos NV, Fagron NV and UCB SA.